EW Financial Facts
Interest (income) expense, net: 2.1MDiluted (in dollars per share): 0.65
See Full Income Statement
Deferred income taxes: 189.3M
Investments in unconsolidated affiliates (Note 6): 467.5M
See Full Balance Sheet
Edwards Lifesciences Corp. (EW) Earnings
|
Expand Research on EW
| Next EPS Date | 4/25/24 | EPS Growth Rate | +3.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +0.8% | Revenue Growth Rate | +8.2% |
| Average % Move 1-Wk after EPS | -5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $0.64 | N/A | N/A | $1.58B | = | N/A | N/A | ||
| 2/6/24 | Q423 | $0.64 | $0.64 | $0.00 | $1.53B | $1.5B | = |  | | Details | |
| 10/25/23 | Q323 | $0.59 | $0.59 | $0.00 | $1.48B | $1.48B |  |
| | Details | |
| 7/26/23 |
Q223 | $0.66 | $0.65 | +$0.01 | $1.53B | $1.5B | |
| | Details | |
| 4/27/23 | Q123 | $0.62 | $0.61 | +$0.01 | $1.46B | $1.39B | = | | | Details | |
| 1/31/23 | Q422 | $0.64 | $0.61 | +$0.03 | $1.35B | $1.33B | = | | | Details | |
| 10/27/22 | Q322 | $0.61 | $0.62 | -$0.01 | $1.32B | $1.33B | = | | | Details | |
| 7/28/22 |  |
Q222 | $0.63 | $0.64 | -$0.01 | $1.37B | $1.4B | = | | | Details |
